http://www.advfn.com/nasdaq/rss.asp?symbol=OMPI Obagi Medical Products Company Newsfeed en Mon, 08 Apr 2013 09:20:17 EDT Mon, 08 Apr 2013 09:20:17 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=OMPI&article=57066219&headline=u-s-hot-stock-futures-hot-stocks-to-watch http://www.advfn.com/nasdaq/StockNews.asp?stocknews=OMPI&article=57066219&headline=u-s-hot-stock-futures-hot-stocks-to-watch <div class='newsbody'><p> Among the companies with shares expected to actively trade in Monday's session are Lufkin Industries Inc. (LUFK), Obagi Medical Products Inc. (OMPI) and Constellation Brands Inc. (STZ). </p> <p> General Electric Co. (GE) confirmed it agreed to buy Lufkin for about $3.3 billion... Mon, 08 Apr 2013 09:20:17 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=OMPI&article=57064615&headline=merz-pharma-withdraws-offer-for-obagi-medical-after-valeants http://www.advfn.com/nasdaq/StockNews.asp?stocknews=OMPI&article=57064615&headline=merz-pharma-withdraws-offer-for-obagi-medical-after-valeants <div class='newsbody'><pre> By Tess Stynes </pre> <p> Merz Pharma Group withdrew its roughly $385 million offer to acquire Obagi Medical Products Inc. (OMPI), citing Valeant Pharmaceuticals International Inc.'s (VRX, VRX.T) sweetened bid for the specialty pharmaceutical company last week. </p> <p> "Obagi... Mon, 08 Apr 2013 08:22:08 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=OMPI&article=57009310&headline=valeant-boosts-price-for-obagi-to-420-million-besting-merz http://www.advfn.com/nasdaq/StockNews.asp?stocknews=OMPI&article=57009310&headline=valeant-boosts-price-for-obagi-to-420-million-besting-merz <div class='newsbody'><pre> By Ben Fox Rubin </pre> <p> Valeant Pharmaceuticals International Inc. (VRX, VRX.T) agreed to raise its offer for Obagi Medical Products Inc. (OMPI) by 22%, besting Merz Pharma Group's recently disclosed bid for the specialty pharmaceutical company. </p> <p> Valeant now will... Wed, 03 Apr 2013 09:02:50 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=OMPI&article=56989552&headline=merz-pharma-offers-to-buy-obagi-looks-to-top-valeant-deal http://www.advfn.com/nasdaq/StockNews.asp?stocknews=OMPI&article=56989552&headline=merz-pharma-offers-to-buy-obagi-looks-to-top-valeant-deal <div class='newsbody'><pre> By Ben Fox Rubin </pre> <p> Merz Pharma Group has offered to buy specialty pharmaceutical company Obagi Medical Products Inc. (OMPI) for about $385 million, looking to top a $345 million bid from Valeant Pharmaceuticals International Inc. (VRX, VRX.T) a few weeks ago. </p> <p>... Tue, 02 Apr 2013 08:44:11 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=OMPI&article=56830722&headline=valeant-pharmaceuticals-agrees-to-acquire-obagi-medical-for-360 http://www.advfn.com/nasdaq/StockNews.asp?stocknews=OMPI&article=56830722&headline=valeant-pharmaceuticals-agrees-to-acquire-obagi-medical-for-360 <div class='newsbody'><pre> By Tess Stynes </pre> <p> Valeant Pharmaceuticals International Inc. (VRX, VRX.T) agreed to acquire Obagi Medical Products Inc. (OMPI) for about $360 million, a deal expected to supplement Valeant's presence in the dermatology and plastic-surgery sectors. </p> <p> Under the... Wed, 20 Mar 2013 10:59:27 EDT